← Back to headlines
Medtronic MiniMed Seeks $784 Million in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking $784 million in its upcoming US Initial Public Offering.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
